PET-CT在儿科肿瘤中的临床应用

王嘉兴; 朱汇庆; 王嘉兴; 朱汇庆

doi:10.3760/cma.j.issn.1673-4114.2009.01.030

[1]

Jadvar H,Connolly LP,Fahey FH,et al.PET and PET/CT in pediatric oncology.Semin Nucl Med,2007,37(5):316-331.

[2]

Gelfand MJ,Lemen LC.PET/CT and SPECT/CT dosimetry in children:The challenge to the pediatric imager.Semin Nucl Med,2007,37(5):391-398.

[3]

Hahn K.Pfluger T.Is PET/CT necessary in paediatric oncolngy? Against.Eur J Nucl Med Mol Imaging,2006,33(8):966-968.

[4]

Munson S,Eshel N,Ernst M,et al.Ethics of PET research in children//charron M.Pediatric PET imaging.New York:Springer New York,2006:72-91.

[5]

Nanni C,Rubello D,CasteUueci P,et al.¹⁸F-FDG PET/CT fusion imaging in pediatric solid extracranial turnouts.Biomed Pharnmacother,2006,60(9):593-606.

[6]

Wegner EA,Barrington SF,Kingston JE,et al.The impact of PET scanning on management of pediatric oncology patients.Eur J Nucl Med Mol Imaging,2005,32(1):23-30.

[7]

Kabickova E,Sumeraner D,Cumlivska E,et al.Comparison of ¹⁸F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease.Eur Nucl Med Mol Imaging,2006,33(9):1025-1031.

[8]

Miller E,Metser U,Avrahami G,et al.Role of ¹⁸F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients.J Comput Assist Tomogr,2006,30(4):689-694.

[9]

Certh HU,Juergens KU,Dirkson U,et al.Significant benefit of multimodal imaging:PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.J Nucl Med,2007,48(12):1932-1939.

[10]

Liuabery AM,Ross JA.Trends in childhood cancer incidence in the U.S.(1992-2004).Cancer,2008,112(2):416-432.

[11]

Tatsumi M,Miller JH,Wahl RL.¹⁸F-FDG PET/CT in evaluating non-CNS pediatric malignancies.J Nucl Med,2007,48(12):1923-1931.

[12]

Rhodes MM,Delbeke D,Whitlock JA,et al.Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma-J Pediatr Hematol Oncol,2006,28(5):300-306.

[13]

Patil S,Biassoni L,Borgwardt L Nuclear medicine in pediatric neurology and neurosurgery:epilepsy and brain tumors.Semin Nucl Med,2007,37(5):357-381.

[14]

Ishola TA,Chung DH.Neuroblastoma.Surg Oncol,2007,16(3):149-156.

[15]

Maris JM,Hogarty MD,Bagatell R.et al.Neuroblastoma.Lancet,2007,369(9579):2106-2120.

[16]

Federman N,Feig SA.PET/CT in evaluating pediatric malignancies:a clinician's perspective.J Nucl Med,2007,48(12):1920-1922.

[17]

Chawla M,NC,Agarwala S,et al.Serial renal dynamic scintigraphy in evaluation of renal function in patient with bilateral Wilms' tumors.Clin Nucl Med,2005,30(12):820-822.

[18]

McLean TW,Castellino SM.Pediatric genitourinary tumors.Curr Opin Oncol,2008,20(3):315-320.

[19]

Misch D,Steffen IG,Schonberger S,et al.Use of positron emission temography for staging,preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.Eur J Nucl Med Mol Imaging,2008,35(9):1642-1650.

[20]

Leaphart C,Rodeberg D.Pediatric surgical ontology:management of rhabdomyosarcoma.Surg Oncol,2007,16(3):173-185.

[21]

Klem ML,Grewal RK,Wexler LH,et al.PET for staging in rhabdornyosarcoma:an evaluation of PET as an adjunct to current staging tools.J Pediatr Hematol Oncol,2007,29(1):9-14.

[22]

Peng F,Rabkin G,Muzik O.Use of 2-doxy-2-[F-18]-fluoro-Dglucose positron emission tomography to monitor therapeutic response by rhabdomyosareoma in children:report of a retrospective case study.Clin Nucl Med,2006,31(7):394-397.